016790 — CanariaBio Share Price
Last trade - 00:00- KR₩187bn
- KR₩294bn
- KR₩161bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -97.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 118,172.5 | 107,476.95 | 110,306.01 | 158,095.62 | 160,600.8 | n/a | n/a | 8.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +38792.78 | -3.01 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CanariaBio Inc, formerly Hyundai Feed Inc, is a Korea-based company mainly engaged in the manufacture and sale of livestock feeds. The Company operates its business through two segments. The Feed segment is mainly engaged in the production and sale of products such as poultry feeds, pig feeds, quail feeds, and other feeds. The Other segment is mainly engaged in the manufacture and sale of raw materials. The Company is also engaged in the rental of real estate. The Company sells its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 5th, 1983
- Public Since
- June 1st, 2018
- No. of Shareholders
- 59,647
- No. of Employees
- 90
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 188,471,729
- Address
- 23, Yongsugol-gil, Dongnam-gu, Cheonan, 31202
- Web
- http://www.hdfeed.co.kr/
- Phone
- +82 415638200
- Auditors
- Samil Accounting Corp.
Upcoming Events for 016790
Similar to 016790
Asia Seed Co
Korea Exchange - KOSDAQ
Bifido Co
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
ByOn Co
Korea Exchange - KOSDAQ
Cherrybro Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:04 UTC, shares in CanariaBio are trading at KR₩994. This share price information is delayed by 15 minutes.
Shares in CanariaBio last closed at KR₩994 and the price had moved by -83.28% over the past 365 days. In terms of relative price strength the CanariaBio share price has underperformed the FTSE Developed Asia Pacific Index by -83.17% over the past year.
The overall consensus recommendation for CanariaBio is Hold. You can view the full broker recommendation list by unlocking its StockReport.
CanariaBio does not currently pay a dividend.
CanariaBio does not currently pay a dividend.
CanariaBio does not currently pay a dividend.
To buy shares in CanariaBio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩994, shares in CanariaBio had a market capitalisation of KR₩187bn.
Here are the trading details for CanariaBio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 016790
Based on an overall assessment of its quality, value and momentum CanariaBio is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CanariaBio. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -81.94%.
As of the last closing price of KR₩994, shares in CanariaBio were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CanariaBio PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩994.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on CanariaBio's directors